Guidelines for the management of pemphigus vulgaris (Q34543406)

2 August 2017

title

Guidelines for the management of pemphigus vulgaris (English)

1 reference

British Association of Dermatologists

2 August 2017

1 reference

pemphigus vulgaris

1 reference

based on heuristic

inferred from title

author

series ordinal

4

object named as

British Association of Dermatologists

1 reference

2 August 2017

K E Harman

1

1 reference

2 August 2017

S Albert

series ordinal

2

1 reference

2 August 2017

M M Black

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

British Journal of Dermatology

2 August 2017

published in

1 reference

2 August 2017

volume

149

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

926-937

1 reference

Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

The adjuvant therapy of pemphigus. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Correlation of Antibodies in Skin and Serum With Disease Severity in Pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Pemphigus: a 20-year review of 107 patients treated with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Pemphigus: a survey of 85 patients between 1970 and 1974

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Pemphigus treatment with azathioprine. Clinical and immunologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Pituitary-adrenal function following dexamethasone-cyclophosphamide pulse therapy for pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Management of pemphigus with gold compounds: a long-term follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Childhood pemphigus vulgaris treated with dapsone: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Experimental dermatology . Original article

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.2003.05665.X

10.1111/J.1365-2133.2003.05665.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference